Case Report Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma Mehmet Emin Sezgin MD, Mustafa Çolak MD, Özge Çağlayan MD, Merve Yumrukuz Şenel MD, Esma Nur Aktepe Sezgin MD, Hikmet Çoban MD, Nurhan Sarıoğlu MD, Bilun Gemicioğlu MD & Fuat Erel MD Pages: 1-3 | DOI: 10.1080/02770903.2023.2244590 “Patient remodeling” as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend Margherita Perlato MD, Valentina Mecheri MD, Emanuele Vivarelli MD, Matteo Accinno BSc, Alessandra Vultaggio MD, PhD & Andrea Matucci MD Pages: 1-4 | DOI: 10.1080/02770903.2023.2241910 Research Article Health-related quality of life, anxiety, depression, beliefs of medication, and self-efficacy in individuals with severe asthma – a population-based study | L. Rönnebjerg MSc(Nurs.), M. Axelsson PhD, H. Kankaanranta MD, PhD & L. Ekerljung MD, PhD Pages: 1-12 | DOI: 10.1080/02770903.2023.2248512 In symptomatic patients on as-needed inhaled corticosteroids-formoterol, VAS asthma is associated with small airways resistance Ilgim Vardaloglu MD, Bernardo Sousa-Pinto MD, PhD, Jean Bousquet MD, PhD, Peter Dodek MD, M.HSC, Anna Bedbrook BSc, Mert Karatas MD & Bilun Gemicioglu MD, PhD Pages: 1-8 | DOI: 10.1080/02770903.2023.2248485 Feasibility of text message follow-up for pediatric asthma care after an emergency department visit Kaitlin Hall, Frances Barry, Lindsey R Thompson, Bahareh Ravandi, Jeanine E Hall, Todd P Chang, Jill S Halterman, Peter G Szilagyi & Sande O Okelo Pages: 1-12 | DOI: 10.1080/02770903.2023.2248507This is the author accepted version which has not been proofed or edited Genetic relationships between high blood eosinophil count, asthma susceptibility, and asthma severity Huashi Li MS & Xingnan Li PhD Pages: 1-13 | DOI: 10.1080/02770903.2023.2247490 Review Article Pediatric Asthma Exacerbation and COVID-19 Pandemic: Impacts, Challenges, and Future Considerations Soroush Khojasteh-Kaffash, Peyvand Parhizkar Roudsari, Amir Ghaffari Jolfayi, Noosha Samieefar & Nima Rezaei Pages: 1-15 | DOI: 10.1080/02770903.2023.2251062This is the author accepted version which has not been proofed or edited |
Recent Posts
- Quick Take: Depemokimab in Severe Asthma
- Analysis of the correlations and inconsistencies between spirometry and impulse oscillometry in the diagnosis of small-airway dysfunction
- Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care
- Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022
- Allergen Immunotherapy: Optimal Duration for Respiratory Allergy